Company profile: Biosynthetic Technologies
1.1 - Company Overview
Company description
- Provider of biobased synthetic molecules and oils made from organic fatty acids found in plant oils for lubricant, chemical, and cosmetics applications. Products include Estolides and BioEstolides, sustainable industrial lubricant base oils, metalworking fluid additives, hydraulic oils, and personal care ingredients offering stability, lubricity, wear protection, and biodegradability.
Products and services
- Industrial Lubricants: Estolide-based sustainable base oils for environmentally friendly industrial lubricants, available in a range of viscosities and additive-compatible with common additives for reliable performance
- Estolides: Biobased synthetic compounds from organic fatty acids in plant oils used as lubricant base oils, delivering hydrolytic stability, oxidative stability, and biodegradable performance across varied formulations
- BioEstolides: Non-toxic sustainable plant-based oils for personal care and beauty products, offering enhanced stability and long-lasting moisturization as specialty ingredients
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biosynthetic Technologies
Ossiform
HQ: Denmark
Website
- Description: Provider of 3D bone printing solutions, including P3D Bone - bio-integrative, resorbable implants made from beta-tricalcium phosphate tailored to biomechanical needs; P3D Scaffolds - 3D printed bioceramic structures for cell culture, disease modeling, and drug screening; and Bone Printing Technology using beta-tricalcium phosphate to create implants with customizable porosity and mechanical properties.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ossiform company profile →
Afyren
HQ: France
Website
- Description: Provider of biotechnological and green chemistry solutions that valorize non-food biomass into biosourced molecules and natural organic acids. Offers AFYREN NEOXY production facility, FLAVYREN flavor and fragrance acids with a low carbon footprint, and a circular eco approach using organic waste and aiming for zero industrial waste via by-product valorization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Afyren company profile →
Bioventix
HQ: United Kingdom
Website
- Description: Provider of high-affinity sheep monoclonal antibodies, specializing in their creation and supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioventix company profile →
Double Bond Pharmaceutical
HQ: Sweden
Website
- Description: Provider of first-in-class pharmaceutical therapies and drug delivery solutions for cancers, infections, autoimmune diseases and other life-threatening disorders. Offers the BeloGal biomimetic encapsulation platform and pipeline candidates including SI-053 for brain cancer, SA-033 targeting doxorubicin to the liver, and Belopenem directing meropenem to infected lungs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Double Bond Pharmaceutical company profile →
Keyence
HQ: Japan
Website
- Description: Provider of sensors (photoelectric, fiber optic, laser, inductive proximity, vision), measurement sensors (laser profilers, displacement sensors, optical micrometers), machine vision systems, barcode readers, laser markers, process sensors (flow, pressure, temperature), safety equipment (light curtains, laser scanners, interlock switches), and digital/laser microscopes for factory automation and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Keyence company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biosynthetic Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biosynthetic Technologies
2.2 - Growth funds investing in similar companies to Biosynthetic Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biosynthetic Technologies
4.2 - Public trading comparable groups for Biosynthetic Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →